Académique Documents
Professionnel Documents
Culture Documents
2 weeks
Put 10-15% on mid cap
Don't touch small cap
No IT sector right
In 2019, Pharma will bounce up -- india exports because of less manufacturing costs -- 20 year patent getting expired therefore
FMCG sector evergreen - CAGR (Don’t every compare inter-sector companies)
Compare CAGRs of all same sector companies such as Dabur/HUL etc.. Check 3-5 yer Balance Sheet (If Debt is increasing since
Check government policies related to sector such as GST (is impac negsative or positive)
Equity of a company in a market -- if it is reducing annually then when company reaches strong position - it reduces market eq
If big news is coming do not touch the stock , for example at the time of budget, election
Revenue up, equity stable - good, if equity is rising too much then its okay , reserves and surplus - if it is saved then it is not suc
If company's equity is rising that means that banks are not giving loan to the company
If a company is at high end then don’t touch it.. Because people are going to pull out so it will go on
If a company is coming at low range why it is at this point
Cipla Ltd. Year Sun Pharma
Ratio 2017 2016 2015 2014 2013 Ratio
Ni/Sales 8.88% 12.07% 11.66% 14.80% 18.37% Ni/Sales
Sales/Assets 70.32% 79.52% 66.69% 72.58% 71.37% Sales/Assets
Assets/Equity 96.9995 94.8409883 94.600037 80.4832482252 71.57311 Assets/Equity
Year
2017 2016 2015 2014 2013
24.88% 25.23% 24.58% 26.00% 17.70%
70.74% 78.81% 88.60% 101.60% 101.09%
197.6112 157.9687 122.4439 98.11508 78.71445
Mar 17 Mar-16 Mar-15 Mar-14 Mar-13
SHAREHOLDER'S FUNDS
NON-CURRENT LIABILITIES
CURRENT LIABILITIES
Short Term Borrowings 324.26 1,131.68 1,380.20 876.91 965.26
Trade Payables 1,298.21 990.84 1,496.60 962.56 827.09
Other Current Liabilities 685.43 582.73 352.42 333.2 242.62
NON-CURRENT ASSETS
Long Term Loans And Advances 215.75 219.37 576.71 535.3 373.72
CURRENT ASSETS
NON-CURRENT INVESTMENTS
CURRENT INVESTMENTS
Income
Expenditure
Miscellaneous
2,975.73 2,859.50 2,401.38 2,069.50 1,753.43
Expenses
Mar '17 Mar '16 Mar '15 Mar '14 Mar '13
Corporate Dividend
0 0 32.69 27.29 27.29
Tax
Shares in issue
8,045.10 8,033.84 8,029.60 8,029.21 8,029.21
(lakhs)
Earning Per Share
12.12 18.2 14.71 17.29 18.77
(Rs)
SHAREHOLDER'S FUNDS
NON-CURRENT LIABILITIES
CURRENT LIABILITIES
ASSETS
NON-CURRENT ASSETS
Long Term Loans And Advances 549.2 639.6 553.8 535.8 350.1
CURRENT ASSETS
Short Term Loans And Advances 105.7 832.6 865.7 828.7 888.5
CONTINGENT LIABILITIES,
COMMITMENTS
REMITTANCES IN FOREIGN
CURRENCIES FOR DIVIDENDS
NON-CURRENT INVESTMENTS
CURRENT INVESTMENTS
Income
Expenditure
Other Manufacturing
87 94.2 92.4 78.5 59.2
Expenses
Mar '17 Mar '16 Mar '15 Mar '14 Mar '13
SHAREHOLDER'S FUNDS
NON-CURRENT LIABILITIES
CURRENT LIABILITIES
Short Term Borrowings 579.62 372.96 20.95 115.16 526.09
Trade Payables 1,478.49 1,128.94 1,042.04 983.85 869.42
Other Current Liabilities 367.03 342.45 101.48 126.51 218.93
NON-CURRENT ASSETS
CURRENT ASSETS
CONTINGENT LIABILITIES,
COMMITMENTS
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted
- - - - -
Market Value
Non-Current Investments
4,801.92 3,740.82 1,790.26 989.05 688.04
Unquoted Book Value
CURRENT INVESTMENTS
Income
Expenditure
Mar '17 Mar '16 Mar '15 Mar '14 Mar '13
SHAREHOLDER'S FUNDS
NON-CURRENT LIABILITIES
ASSETS
NON-CURRENT ASSETS
Long Term Loans And Advances 4.85 2,165.47 1,895.23 761.49 491.09
CURRENT ASSETS
Current Investments 40.01 82.49 93.93 860 941.05
Inventories 2,286.62 2,132.16 2,189.25 918.38 868.76
Trade Receivables 2,725.67 2,016.81 1,802.82 452.75 737.53
Cash And Cash Equivalents 163.81 169.39 416.46 141.48 431.12
Short Term Loans And Advances 13.82 745.03 696.69 309.32 849.5
OtherCurrentAssets 1,139.93 197.82 251.13 2,490.11 59.29
Total Current Assets 6,369.86 5,343.70 5,450.28 5,172.04 3,887.25
Total Assets 33,748.23 34,189.93 37,445.55 13,837.00 9,246.49
NON-CURRENT INVESTMENTS
CURRENT INVESTMENTS
Income
Expenditure
Mar '17 Mar '16 Mar '15 Mar '14 Mar '13